Sign in

CIK 0001806952

  • Non-accelerated filer
  • Smaller reporting company

Lyell Immunopharma, Inc.

Sign in to watch
Ticker
LYEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
833006753
Phone
+1 650-695-0677
Business address
201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$49,999,983
in 2 filings
Open-market sales, last 90 days
$28,757
in 6 filings

Net +$49,971,226. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-02-10 Lang Matthew Chief Business Officer Grant or award +112,500 162,500
2025-02-10 Lang Matthew Chief Business Officer Grant or award · Option (right to buy) +450,000 450,000
2025-02-10 Lang Matthew Chief Business Officer Grant or award · Option (right to buy) +56,250 56,250
2024-02-09 Lang Matthew Chief Business Officer Grant or award +50,000 50,000
2024-02-09 Lang Matthew Chief Business Officer Grant or award · Option (right to buy) +500,000 500,000
2023-08-10 Lang Matthew Chief Business Officer Grant or award · Option (right to buy) +2,250,000 2,250,000

Page 1 of 1 · 6 trades